Get an early start on your networking for South Summit 2018 by checking out our marketplace, where you can find profiles on all the Startups, Corporate Partners, Accelerators and Institutions who will be at the event.

I look for a relationships with a

Working on

Who can help my project via

  • Conquerx
TypeStartup Country United States Startup interested in Funding, Strategic Partnerships, Visibility, Talent, Accelerator Programme
  • ConquerX
  • Biotech
  • |
  • Founded in 2016
  • |
  • 0 employees

ConquerX’s Ebegen technology provides customizable molecular profiling solutions to help decrease the cost and time of clinical trials, enabling drug efficacy measurement as well as fast and accurate stratification of patients. EbeGen is an electrochemical biosensor that can analyze multiple types of molecular targets in a single sample, without the need for amplification or sequencing, and ten times faster (total time of 30 min) than current technologies. While delivering faster results on biomarkers analysis, EbeGen enables quicker identification of low effectiveness compounds, saving precious save R&D time. EbeGen can save up to 10% of the cost per phase by reducing research of components with low effectiveness, and/or incorrect doses, as well as trials with patients not genetically susceptible to the drug.

If you have a proposal on some of these areas, we will gladly analyze:

Jorge Sánchez

Jorge Sánchez